Cargando…
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
BACKGROUND: The development of diagnostic tools capable of accurately identifying the pathophysiology of mild cognitive impairment (MCI) has become a crucial target considering the claim that disease-modifying treatments should be administered as early as possible in the disease course. Transcranial...
Autores principales: | Padovani, Alessandro, Benussi, Alberto, Cotelli, Maria Sofia, Ferrari, Clarissa, Cantoni, Valentina, Dell’Era, Valentina, Turrone, Rosanna, Paghera, Barbara, Borroni, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886207/ https://www.ncbi.nlm.nih.gov/pubmed/31787103 http://dx.doi.org/10.1186/s13195-019-0555-3 |
Ejemplares similares
-
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
por: Benussi, Alberto, et al.
Publicado: (2018) -
Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial
por: Benussi, Alberto, et al.
Publicado: (2020) -
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease
por: Fornari, Chiara, et al.
Publicado: (2022) -
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers
por: Benussi, Alberto, et al.
Publicado: (2019) -
Altered brain metabolic connectivity at multiscale level in early Parkinson’s disease
por: Sala, Arianna, et al.
Publicado: (2017)